Product Overview
Tesamorelin – Research‑Grade GHRH Analogue for Endocrine and Metabolic Pathway Investigation
Synonyms: TH9507; Growth Hormone‑Releasing Hormone (GHRH) Analogue
CAS Number: 218949‑48‑5
Sequence: Tyr‑Ala‑Asp‑Ala‑Ile‑Phe‑Thr‑Asn‑Ser‑Tyr‑Arg‑Lys‑Val‑Leu‑Ala‑Gln‑Leu‑Ser‑Ala‑Arg‑Lys‑Leu‑Leu‑Gln‑Asp‑Ile‑Met‑Ser‑Arg‑Gln‑Gln‑Gly‑Glu‑Ser‑Asn‑Gln‑Glu‑Gln‑Glu‑Glu‑Ala‑Glu‑Ala‑Glu‑Glu‑Ala‑Glu‑Ala‑Glu‑Glu‑Ala‑Glu‑Ala‑Glu‑Glu‑Ala‑Glu‑Ala‑Glu‑Glu‑Ala‑Glu‑Ala‑Glu‑Glu‑Ala‑Glu‑Ala‑Glu‑Glu‑Ala‑Glu‑Ala‑Glu‑Glu‑Ala‑Glu‑Ala‑Glu‑Glu
(Note: Sequence may be presented in truncated form depending on supplier conventions.)
Molecular Weight: Approx. 5,115 Da
Form: Lyophilised powder
Purity: ≥98% (HPLC)
Use: For laboratory research only. Not for human or veterinary use.
Overview
Tesamorelin is a synthetic analogue of growth hormone‑releasing hormone (GHRH), engineered to investigate endocrine signalling, metabolic regulation, and growth hormone axis dynamics in controlled laboratory models.
Research focuses on its ability to stimulate GHRH‑related pathways, influence IGF‑1‑associated signalling, and modulate metabolic processes in non‑human systems.
Its stability and receptor‑targeted design make it suitable for in vitro and in vivo studies examining endocrine feedback loops, metabolic homeostasis, and peptide–receptor interactions.
Mechanistic Insights
Preclinical research has explored Tesamorelin in relation to several biological mechanisms:
• GHRH Receptor Activation – Studied for its ability to stimulate GHRH‑dependent signalling cascades in non‑human models.
• Growth Hormone Axis Modulation – Investigated for its influence on GH secretion and downstream IGF‑1‑related pathways.
• Metabolic Regulation – Examined for its involvement in lipid turnover, glucose handling, and energy‑balance mechanisms.
• Endocrine Feedback Dynamics – Evaluated for its role in hypothalamic–pituitary signalling and regulatory loops.
These findings are based on published scientific literature and do not imply any therapeutic or physiological effects in humans.
Research Context
Tesamorelin is utilised exclusively within controlled laboratory environments for:
• Studies involving endocrine signalling and GH/IGF‑1 axis regulation
• Investigations into metabolic pathways and energy‑balance models
• Research on peptide–receptor interactions and hypothalamic–pituitary dynamics
• Comparative studies with other GHRH analogues or metabolic peptides
This material is not intended for therapeutic, diagnostic, or clinical use.
Packaging & Storage
• Supplied as a sterile‑filtered, lyophilised peptide
• Store at –20°C, protected from light and moisture
• Reconstitute under sterile laboratory conditions using bacteriostatic water or a suitable research‑grade diluent
• Store reconstituted solutions at 2–8°C and use according to institutional guidelines
Additional solubility and technical documentation are available to qualified research institutions upon request.
Compliance Notice
This product is intended solely for laboratory research purposes.
It is not approved for human or veterinary administration and must not be incorporated into food, cosmetics, pharmaceuticals, or any product intended for biological exposure.
All information provided is for scientific and educational reference only. Researchers are responsible for ensuring compliance with all applicable regulations, institutional policies, and safety standards.
